These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26376555)

  • 1. Stress Ulcer Prophylaxis use in the Intensive care Unit before and after House Staff Education.
    Meena N; Costner M; Joshi M
    J Ark Med Soc; 2015 Aug; 112(3):38-40. PubMed ID: 26376555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why do physicians prescribe stress ulcer prophylaxis to general medicine patients?
    Hussain S; Stefan M; Visintainer P; Rothberg M
    South Med J; 2010 Nov; 103(11):1103-10. PubMed ID: 21042168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased acid suppression therapy overuse after education and medication reconciliation.
    Gupta R; Marshall J; Munoz JC; Kottoor R; Jamal MM; Vega KJ
    Int J Clin Pract; 2013 Jan; 67(1):60-5. PubMed ID: 23241049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress ulcer prophylaxis: reducing non-indicated prescribing after hospital discharge.
    Hatch JB; Schulz L; Fish JT
    Ann Pharmacother; 2010 Oct; 44(10):1565-71. PubMed ID: 20841521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overuse of stress ulcer prophylaxis in the critical care setting and beyond.
    Farrell CP; Mercogliano G; Kuntz CL
    J Crit Care; 2010 Jun; 25(2):214-20. PubMed ID: 19683892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit.
    Preslaski CR; Mueller SW; Kiser TH; Fish DN; MacLaren R
    J Clin Pharm Ther; 2014 Dec; 39(6):658-62. PubMed ID: 25243327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
    Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
    Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress ulcer prophylaxis for non-critically ill patients on a teaching service.
    Hwang KO; Kolarov S; Cheng L; Griffith RA
    J Eval Clin Pract; 2007 Oct; 13(5):716-21. PubMed ID: 17824863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency.
    Mousavi M; Dashti-Khavidaki S; Khalili H; Farshchi A; Gatmiri M
    Int J Pharm Pract; 2013 Aug; 21(4):263-9. PubMed ID: 23418812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
    Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
    Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pharmacy resident led education on resident physician prescribing habits associated with stress ulcer prophylaxis in non-intensive care unit patients.
    Agee C; Coulter L; Hudson J
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S48-52. PubMed ID: 25991596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients.
    Heidelbaugh JJ; Inadomi JM
    Am J Gastroenterol; 2006 Oct; 101(10):2200-5. PubMed ID: 16952283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic benefit of practice guidelines for stress ulcer prophylaxis.
    Mostafa G; Sing RF; Matthews BD; Pratt BL; Norton HJ; Heniford BT
    Am Surg; 2002 Feb; 68(2):146-50. PubMed ID: 11842960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-year trends of inappropriate proton pump inhibitor use after hospital discharge.
    Leri F; Ayzenberg M; Voyce SJ; Klein A; Hartz L; Smego RA
    South Med J; 2013 Apr; 106(4):270-3. PubMed ID: 23558416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate continuation of stress ulcer prophylaxis beyond the intensive care setting.
    Farley KJ; Barned KL; Crozier TM
    Crit Care Resusc; 2013 Jun; 15(2):147-51. PubMed ID: 23961576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate continuation of stress ulcer prophylactic therapy after discharge.
    Wohlt PD; Hansen LA; Fish JT
    Ann Pharmacother; 2007 Oct; 41(10):1611-6. PubMed ID: 17848420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief report: Reducing inappropriate usage of stress ulcer prophylaxis among internal medicine residents. A practice-based educational intervention.
    Liberman JD; Whelan CT
    J Gen Intern Med; 2006 May; 21(5):498-500. PubMed ID: 16704396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label use of gastrointestinal medications in the intensive care unit.
    Barletta JF; Lat I; Micek ST; Cohen H; Olsen KM; Haas CE;
    J Intensive Care Med; 2015 May; 30(4):217-25. PubMed ID: 24362446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis.
    Zeigler AJ; McAllen KJ; Slot MG; Barletta JF
    Ann Pharmacother; 2008 Jul; 42(7):940-6. PubMed ID: 18577762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prescribing practices in a teaching clinic: comparison of resident and staff physicians.
    Mincey BA; Parkulo MA
    South Med J; 2001 Apr; 94(4):365-9. PubMed ID: 11332898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.